219 related articles for article (PubMed ID: 35381903)
1. Persistence and recurrence in tumor-induced osteomalacia: A systematic review of the literature and results from a national survey/case series.
Cianferotti L; Delli Poggi C; Bertoldo F; Caffarelli C; Crotti C; Gatti D; Giannini S; Gonnelli S; Mazzantini M; Ombretta V; Sella S; Setti A; Varenna M; Zucchi F; Brandi ML
Endocrine; 2022 Jun; 76(3):709-721. PubMed ID: 35381903
[TBL] [Abstract][Full Text] [Related]
2. Long-term use of burosumab for the treatment of tumor-induced osteomalacia.
Crotti C; Zucchi F; Alfieri C; Caporali R; Varenna M
Osteoporos Int; 2023 Jan; 34(1):201-206. PubMed ID: 35925260
[TBL] [Abstract][Full Text] [Related]
3. Favorable effects of burosumab on tumor-induced osteomalacia caused by an undetectable tumor: A case report.
Oe Y; Kameda H; Nomoto H; Sakamoto K; Soyama T; Cho KY; Nakamura A; Iwasaki K; Abo D; Kudo K; Miyoshi H; Atsumi T
Medicine (Baltimore); 2021 Nov; 100(46):e27895. PubMed ID: 34797338
[TBL] [Abstract][Full Text] [Related]
4. Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia.
Jan de Beur SM; Minisola S; Xia WB; Abrahamsen B; Body JJ; Brandi ML; Clifton-Bligh R; Collins M; Florenzano P; Houillier P; Imanishi Y; Imel EA; Khan AA; Zillikens MC; Fukumoto S
J Intern Med; 2023 Mar; 293(3):309-328. PubMed ID: 36511653
[TBL] [Abstract][Full Text] [Related]
5. Interim Analysis of a Phase 2 Open-Label Trial Assessing Burosumab Efficacy and Safety in Patients With Tumor-Induced Osteomalacia.
Imanishi Y; Ito N; Rhee Y; Takeuchi Y; Shin CS; Takahashi Y; Onuma H; Kojima M; Kanematsu M; Kanda H; Seino Y; Fukumoto S
J Bone Miner Res; 2021 Feb; 36(2):262-270. PubMed ID: 32967046
[TBL] [Abstract][Full Text] [Related]
6. Hypophosphatemia and FGF23 tumor-induced osteomalacia in two cases of metastatic breast cancer.
Abramson M; Glezerman IG; Srinivasan M; Ross R; Flombaum C; Gutgarts V
Clin Nephrol; 2021 Feb; 95(2):104-111. PubMed ID: 33191899
[TBL] [Abstract][Full Text] [Related]
7. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
[TBL] [Abstract][Full Text] [Related]
8. Tumor induced osteomalacia: A single center experience on 17 patients.
Crotti C; Bartoli F; Coletto LA; Manara M; Marini E; Daolio PA; Parafioriti A; Armiraglio E; Zucchi F; Sinigaglia L; Caporali R; Varenna M
Bone; 2021 Nov; 152():116077. PubMed ID: 34175499
[TBL] [Abstract][Full Text] [Related]
9. X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment.
Kinoshita Y; Fukumoto S
Endocr Rev; 2018 Jun; 39(3):274-291. PubMed ID: 29381780
[TBL] [Abstract][Full Text] [Related]
10. Tumor-induced Osteomalacia: A Systematic Review and Individual Patient's Data Analysis.
Rendina D; Abate V; Cacace G; D'Elia L; De Filippo G; Del Vecchio S; Galletti F; Cuocolo A; Strazzullo P
J Clin Endocrinol Metab; 2022 Jul; 107(8):e3428-e3436. PubMed ID: 35468192
[TBL] [Abstract][Full Text] [Related]
11. Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases.
Bosman A; Palermo A; Vanderhulst J; De Beur SMJ; Fukumoto S; Minisola S; Xia W; Body JJ; Zillikens MC
Calcif Tissue Int; 2022 Oct; 111(4):367-379. PubMed ID: 35857061
[TBL] [Abstract][Full Text] [Related]
12. Burosumab for the Treatment of Tumor-Induced Osteomalacia.
Jan de Beur SM; Miller PD; Weber TJ; Peacock M; Insogna K; Kumar R; Rauch F; Luca D; Cimms T; Roberts MS; San Martin J; Carpenter TO
J Bone Miner Res; 2021 Apr; 36(4):627-635. PubMed ID: 33338281
[TBL] [Abstract][Full Text] [Related]
13. Clinical Challenges in Diagnosis, Tumor Localization and Treatment of Tumor-Induced Osteomalacia: Outcome of a Retrospective Surveillance.
Hidaka N; Koga M; Kimura S; Hoshino Y; Kato H; Kinoshita Y; Makita N; Nangaku M; Horiguchi K; Furukawa Y; Ohnaka K; Inagaki K; Nakagawa A; Suzuki A; Takeuchi Y; Fukumoto S; Nakatani F; Ito N
J Bone Miner Res; 2022 Aug; 37(8):1479-1488. PubMed ID: 35690913
[TBL] [Abstract][Full Text] [Related]
14. Tumor-induced Osteomalacia: A Comprehensive Review.
Minisola S; Fukumoto S; Xia W; Corsi A; Colangelo L; Scillitani A; Pepe J; Cipriani C; Thakker RV
Endocr Rev; 2023 Mar; 44(2):323-353. PubMed ID: 36327295
[TBL] [Abstract][Full Text] [Related]
15. Prolonged Hypophosphatemia and Intensive Care After Curative Surgery of Tumor Induced Osteomalacia: A Case Report.
Ryhänen EM; Schalin-Jäntti C; Matikainen N
Front Endocrinol (Lausanne); 2021; 12():686135. PubMed ID: 34149623
[TBL] [Abstract][Full Text] [Related]
16. Tumour-induced osteomalacia.
Minisola S; Peacock M; Fukumoto S; Cipriani C; Pepe J; Tella SH; Collins MT
Nat Rev Dis Primers; 2017 Jul; 3():17044. PubMed ID: 28703220
[TBL] [Abstract][Full Text] [Related]
17. [Tumor-induced osteomalacia caused by an FGF23-secreting myopericytoma : Case report and literature review].
Muro Bushart N; Tharun L; Oheim R; Paech A; Kiene J
Orthopade; 2020 Jan; 49(1):1-9. PubMed ID: 30937490
[TBL] [Abstract][Full Text] [Related]
18. Tumor-induced osteomalacia combined with increased bone resorption postoperatively: A case report.
Shi L; Tang M; Duan S; Deng F; Zhang Y; Yang J; Hu J
Medicine (Baltimore); 2023 Jul; 102(27):e34217. PubMed ID: 37417620
[TBL] [Abstract][Full Text] [Related]
19. Nonremission and Recurrent Tumor-Induced Osteomalacia: A Retrospective Study.
Li X; Jiang Y; Huo L; Wu H; Liu Y; Jin J; Yu W; Lv W; Zhou L; Xia Y; Wang O; Li M; Xing X; Chi Y; Jiajue R; Cui L; Meng X; Xia W
J Bone Miner Res; 2020 Mar; 35(3):469-477. PubMed ID: 31643101
[TBL] [Abstract][Full Text] [Related]
20. Challenges in the management of tumor-induced osteomalacia (TIO).
Brandi ML; Clunie GPR; Houillier P; Jan de Beur SM; Minisola S; Oheim R; Seefried L
Bone; 2021 Nov; 152():116064. PubMed ID: 34147708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]